Parkinson's disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning

被引：0
|
作者：
Wertz, C.
Poston, K.
Shaff, N.
Hartman, A.
Horner, A.
Mayer, A.
Vakhtin, A.
Deligtisch, A.
Richardson, S. Pirio
Ryman, S.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1055
引用
收藏
页码：S466 / S467
页数：2
相关论文
共 50 条
  • [21] Staging and clinical correlates of cortical thinning in Parkinson's disease
    Wilson, H.
    Niccolini, F.
    Pellicano, C.
    Piccini, P.
    Politis, M.
    MOVEMENT DISORDERS, 2016, 31 : S234 - S234
  • [22] Cortical thinning pattern according to differential nigrosome involvement in patients with Parkinson's disease
    Shin, Na-Young
    Kim, Bo-Hyun
    Yun, Eunkyeong
    Yoon, Uicheul
    Lee, Jong-Min
    Sung, Young Hee
    Kim, Eung Yeop
    NEUROIMAGE-CLINICAL, 2020, 28
  • [23] Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease
    Anglade, P
    Vyas, S
    JavoyAgid, F
    Herrero, MT
    Michel, PP
    Marquez, J
    MouattPrigent, A
    Ruberg, M
    Hirsch, EC
    Agid, Y
    NEUROLOGY, 1996, 46 (02) : 6136 - 6136
  • [24] Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease
    Munoz-Delgado, Laura
    Labrador-Espinosa, Miguel Angel
    Macias-Garcia, Daniel
    Jesus, Silvia
    Benitez Zamora, Belen
    Fernandez-Rodriguez, Paula
    Adarmes-Gomez, Astrid D.
    Reina Castillo, Maria Isabel
    Castro-Labrador, Sandra
    Silva-Rodriguez, Jesus
    Carrillo, Fatima
    Solis, David Garcia
    Grothe, Michel J.
    Mir, Pablo
    MOVEMENT DISORDERS, 2023, 38 (05) : 755 - 763
  • [25] Ventral striatal dopaminergic defect is a risk factor for hallucinations in Parkinson's disease
    Jaakkola, E.
    Joutsa, J.
    Makinen, E.
    Johansson, J.
    Kaasinen, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 93 - 93
  • [26] Cortical and amygdalar Lewy body burden in Parkinson's disease patients with malignant visual hallucinations
    Papapetropoulos, S
    McCorquodale, D
    Gonzalez, J
    Jean-Gilles, L
    Mash, DC
    ANNALS OF NEUROLOGY, 2005, 58 : S20 - S20
  • [27] A nonhuman primate model of Parkinson's disease associated with cortical and subcortical dopaminergic, noradrenergic and serotonergic neuronal degeneration
    Masilamoni, G.
    Weinkle, A. P.
    Bogenpohl, J.
    Groover, O. A.
    Wichmann, T.
    Smith, Y.
    MOVEMENT DISORDERS, 2011, 26 : S23 - S24
  • [28] Progression of small vessel disease correlates with cortical thinning in Parkinson's disease
    Foo, Heidi
    Mak, Elijah
    Yong, Ting Ting
    Wen, Ming-Ching
    Chander, Russell Jude
    Au, Wing Lok
    Tan, Louis
    Kandiah, Nagaendran
    PARKINSONISM & RELATED DISORDERS, 2016, 31 : 34 - 40
  • [29] Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease
    Hong, Jin Yong
    Yun, Hyuk Jin
    Sunwoo, Mun Kyung
    Ham, Jee Hyun
    Lee, Jong-Min
    Sohn, Young H.
    Lee, Phil Hyu
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (09) : 999 - 1003
  • [30] Cortical thinning associated with mild cognitive impairment in Parkinson's disease
    Galantucci, S.
    Agosta, F.
    Stojkovic, T.
    Petrovic, I.
    Stefanova, E.
    Canu, E.
    Copetti, M.
    Kostic, V. S.
    Filippi, M.
    MOVEMENT DISORDERS, 2016, 31 : S417 - S417
12345